Loading clinical trials...
Loading clinical trials...
A Phase I/II Study to Evaluate Safety and Efficacy of the Boron Neutron Capture Therapy (BNCT) Using B10 L-BPA as Boron Carrier in Malignant Brain Tumors.
Conditions
Interventions
B10 L-BPA Injection
Locations
2
Taiwan
China Medical University Hsinchu Hospital
Hsinchu, Taiwan
China Medical University Hospital
Taichung, Taiwan
Start Date
June 30, 2025
Primary Completion Date
June 1, 2026
Completion Date
December 1, 2026
Last Updated
November 18, 2025
NCT07158710
NCT07438860
NCT04171895
Lead Sponsor
China Medical University Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions